These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2862710)

  • 1. [Treatment of vegetovascular dystonia with beta-blockaders and tranquilizers].
    Zubarev IuG; Kulakov SA
    Sov Med; 1985; (3):83-5. PubMed ID: 2862710
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of treating patients with vegetative and vascular crises of a neurotic nature (comparative electrophysiologic study)].
    Veĭn AM; Tabeeva GR; Iakhno NN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(5):684-8. PubMed ID: 2874677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of functional disorders of the cardiovascular system with a new benzodiazepine preparation].
    Matteoli E; Lampugnani E; Zaini G; Riva D
    Minerva Med; 1974 Jun; 65(45):2481-4. PubMed ID: 4602654
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psychopharmacologic treatment of cardiac neurotic patients with dipotassium chlorazepate in double-blind test].
    Schüffel W; Schaumburg C; Schäfer N
    Arzneimittelforschung; 1970 Jan; 20(1):127-30. PubMed ID: 4909438
    [No Abstract]   [Full Text] [Related]  

  • 5. [The differential treatment of patients with neurocirculatory dystonia depending on the type of hemodynamic disorders].
    Tatarintsev AN; Dvorkin AI; Semchenko VM
    Ter Arkh; 1993; 65(11):72-4. PubMed ID: 8108807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications for beta-blockers in other cardiac diseases: rhythm disorders, obstructive cardiomyopathy, cardiothyreosis and neurocirculatory asthenia].
    Guize L; Le Heuzey JY
    Rev Prat; 1984 Apr; 34(19):967-72. PubMed ID: 6144163
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of beta adrenergic receptor blockaders in industrial workers with neurocirculatory asthenia of the hypertensive type].
    Maziĭ SA; Senik EA; Turashvili GA; Zisel'man SB; Kazarian AB
    Sov Med; 1988; (7):96-9. PubMed ID: 3067385
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a short course of beta-blocker treatment on the central hemodynamics and work capacity of patients with neurocirculatory dystonia].
    Pal'tsev IS; Sokova EA; Fisenko LA
    Kardiologiia; 1985 Apr; 25(4):48-52. PubMed ID: 2862304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Length of effect of beta-blockers in hyperkinetic heart syndrome].
    Paulsen HF; Felder K
    ZFA (Stuttgart); 1983 Jul; 59(20):1149-54. PubMed ID: 6137915
    [No Abstract]   [Full Text] [Related]  

  • 10. [Essential circulatory hyperkinesis and tobanum].
    Nagy I
    Orv Hetil; 1982 Feb; 123(9):569. PubMed ID: 6123100
    [No Abstract]   [Full Text] [Related]  

  • 11. Tranquilizers in the treatment of the cardiac neurotic patient and the subsequent alteration of complaints.
    Schüffel W; Schaumburg C
    Psychother Psychosom; 1970; 18(1):307-12. PubMed ID: 4938752
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic use of agents acting on alpha and beta receptors].
    Soballa G
    Fortschr Med; 1974 Apr; 92(11):461-6. PubMed ID: 4150787
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of the individual changes in cardiovascular system reactivity in prescribing adrenergic blockaders].
    Paleev NR; Kaevitser IM; Kublanov LA
    Kardiologiia; 1977 Nov; 17(11):103-8. PubMed ID: 23449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of Tobanum (GYKI-41099) in essential circulatory hyperkinesis, studied by radiocardiography].
    Józan M; Tarján J; Wágner G; Rostás L; Lascsik L; Kovács S; Parti G
    Orv Hetil; 1981 Oct; 122(41):2547-8. PubMed ID: 6119668
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of functional heart disorders with beta-adrenergic blocking agents.
    Imhof P; Brunner H
    Postgrad Med J; 1970 Nov; ():Suppl:96-9. PubMed ID: 4395467
    [No Abstract]   [Full Text] [Related]  

  • 16. [Utilization of psychopharmacological agents in internal medicine].
    Relke W
    Dtsch Gesundheitsw; 1972 Oct; 27(43):2043-6. PubMed ID: 4564076
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of butydrine in various clinical syndromes (cardiovascular neurosis: juvenile hyperkinetic syndrome; thyrotoxicosis)].
    Guardigli R
    Minerva Cardioangiol; 1970 Feb; 18(2):131-40. PubMed ID: 4393800
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurocirculatory dystonia].
    Dobrokhodova TM
    Feldsher Akush; 1990 Jun; 55(6):28-33. PubMed ID: 2209851
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neurocirculatory dystonia].
    Pankratov AB
    Feldsher Akush; 1986 Jul; 51(7):24-9. PubMed ID: 3641723
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of impulse magnet field and beta adrenergic blockaders on physical work capacity and hemodynamics of patients with neurocirculatory dystonia of the cardiac type].
    Orlov LL; Makoeva LD; Glezer MG; Memetov KA; Belinskaia TF; Arzhanenko OM
    Kardiologiia; 1991 Feb; 31(2):36-9. PubMed ID: 2041288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.